Introduction to Nanomedicine
Course, Master's level, 3FG013
Autumn 2023 Autumn 2023, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 29 November 2023–14 January 2024
- Language of instruction
- English
- Entry requirements
-
150 credits, including 120 credits in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering. Previous studies must include (1) physical chemistry and pharmaceutics 13 credits or (2) Molecular Biopharmaceutics 7.5 credits.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits in science and engineering (maximum 240 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 17 April 2023
- Application code
- UU-39005
Admitted or on the waiting list?
- Registration period
- 22 November 2023–29 November 2023
- Information on registration from the department
Autumn 2023 Autumn 2023, Uppsala, 100%, On-campus, English For exchange students
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 29 November 2023–14 January 2024
- Language of instruction
- English
- Entry requirements
-
150 credits, including 120 credits in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering. Previous studies must include (1) physical chemistry and pharmaceutics 13 credits or (2) Molecular Biopharmaceutics 7.5 credits.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
Admitted or on the waiting list?
- Registration period
- 22 November 2023–29 November 2023
- Information on registration from the department
Autumn 2024 Autumn 2024, Uppsala, 100%, On-campus, English
The course is cancelled.
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 4 December 2024–19 January 2025
- Language of instruction
- English
- Entry requirements
-
150 credits, including 120 credits in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering. Previous studies must include (1) physical chemistry and pharmaceutics 13 credits or (2) Molecular Biopharmaceutics 7.5 credits.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits in science and engineering (maximum 240 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application code
- UU-39005
Autumn 2024 Autumn 2024, Uppsala, 100%, On-campus, English For exchange students
The course is cancelled.
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 4 December 2024–19 January 2025
- Language of instruction
- English
- Entry requirements
-
150 credits, including 120 credits in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering. Previous studies must include (1) physical chemistry and pharmaceutics 13 credits or (2) Molecular Biopharmaceutics 7.5 credits.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
About the course
The course covers the principles in nanomedicine, especially with regard to the connection between the physicochemical properties of nanomaterials, possible administration routes and their interactions with cells and tissues in the body. Further, it deals with the behaviour of nanoparticles in biological fluids (e.g. plasma, intestinal fluid) and colloidal stability.
We study the basic principles for active (with ligands) and passive (e.g. for cancer therapy) targeting and uptake of nanoparticles in cells and tissues in the body. Furthermore, the course will cover nanoparticle and nanocarrier properties including the most important synthesis routes and characterisation methods. The special focus is also on diagnostic materials that can be used in imaging techniques or in theranostic formulations that combine disease diagnosis and therapy.
Finally, we will consider the toxic, pharmacokinetic and regulatory aspects of nanomaterials in biomedical applications. For toxicity, this includes a comparison of different external barriers that are exposed to nanomaterials, e.g. in the intestine, lungs, nose and skin.